Diagnostic assay manufacturer with cloud-connected mobile and GPS supply-chain tracking
ProGnosis Biotech manufactures ELISA and lateral-flow diagnostic kits for food safety, clinical, and veterinary markets, distributed across 80+ countries through 10 regional subsidiaries. The tech stack—LabVIEW, Python, C++, MATLAB, Arduino—reflects a hardware-software hybrid business focused on embedded diagnostics and real-time data collection. Current hiring and project focus (e-commerce, UX, paid campaigns) signals a shift toward direct-to-customer and digital channel expansion, a significant departure from their traditional B2B/distributor model.
ProGnosis Biotech is a publicly listed biotechnology company headquartered in Larissa, Greece, founded in 2011. The business manufactures rapid diagnostic assays (ELISA and lateral-flow tests) for mycotoxin, antibiotic, allergen, and histamine detection, with custom manufacturing capabilities. Products are sold through subsidiaries and distribution partners in 80+ countries. The company integrates proprietary hardware (Arduino-based point-of-use devices) with cloud-connected mobile apps and GPS tracking to provide real-time visibility across supply chains. Quality certifications include ISO 9001, ISO 13485, and ISO 37001, with validation from USDA, AOAC, and other regulatory bodies.
Core stack includes LabVIEW, Python, C++, and MATLAB for firmware and data processing; Arduino IDE for device firmware; Fusion 360 for hardware design; AWS for cloud infrastructure; and ChatGPT/GitHub Copilot for development support.
Headquartered in Larissa, Thessaly, Greece. The company operates regional subsidiaries across 10 countries and serves customers in over 80 countries globally.
Other companies in the same industry, closest in size